Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin receptor 5HT1D (5-HT1D, HTR1D) is a subtype of the serotonin receptor family. It is a G protein-coupled receptor (GPCR) that mediates inhibitory neurotransmission by decreasing cellular levels of cyclic AMP (cAMP). It functions primarily in the modulation of neurotransmitter release, particularly serotonin, and is involved in vasoconstriction. Drugs targeting this receptor, such as triptans, are used for acute migraine therapy. Dysfunctions involving this receptor have been implicated in mood disorders including depression and anxiety.
Agonists induce cranial vasoconstriction and inhibit neuropeptide release from trigeminal nerve endings; antagonists block serotonin binding and downstream signaling.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor 5HT1D (None).